Literature DB >> 8587698

Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol.

S Berger1, L Schürer, R Härtl, K Messmer, A Baethmann.   

Abstract

Cerebral injury is seen in one of three patients with multiple traumas; thus efficient shock treatment is a most important measure against the development of secondary brain damage. Small-volume resuscitation in severe hemorrhagic shock by hypertonic/hyperoncotic saline/dextran has been shown to instantaneously normalize cardiac output and to raise systemic blood pressure. In this study, the fluid regimen was compared with hypertonic mannitol to investigate their therapeutic efficacy in intracranial hypertension. The experiments were performed in rabbits subjected to a focal lesion of the brain to induce acute, vasogenic brain edema. The resulting intracranial hypertension was enhanced in a standard manner by inflation of an epidural balloon until an intracranial pressure (ICP) of 17 mm Hg was obtained. Intravenous administration of either 7.2% saline/10% dextran-60 or of 20% mannitol rapidly decreased the elevated ICP. After the first injection, ICP lowering was maintained longer by the mannitol than by the hypertonic saline/dextran, whereas no differences in duration of ICP lowering were found when the infusions of these solutions were repeated. The systemic blood pressure increased after injection of the saline/dextran solution, but it tended to decrease after injection of the mannitol. Transient increases in plasma osmolality, colloid-osmotic pressure, and plasma-Na+ were more pronounced after administration of the saline/dextran solution than after the administration of the mannitol. No difference in the tissue water content between the traumatized and contralateral hemisphere was observed in the animals receiving mannitol; however, after saline/dextran infusion, the water content was somewhat increased in the exposed hemisphere but decreased in the nonexposed, contralateral hemisphere (decreased to a point even below the corresponding level of animals who received the mannitol). The increase of the cerebral water content of the traumatized hemisphere was associated with a respective increase of the cerebral Na+ content and a (nonsignificant) decrease of the K+ content. The present findings demonstrate that the hypertonic/hyperoncotic saline/dextran was as efficient as the mannitol in reducing ICP that had been increased by a cerebral lesion and a space-occupying mass; the underlying mechanisms responsible for the reduction might differ. Because of the powerful hemodynamic properties of the saline/dextran in circulatory shock, administration of the solution in patients with multiple traumas and head injury might be particularly advantageous for the prevention of secondary ischemic brain damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587698     DOI: 10.1227/00006123-199507000-00015

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Salt saves the hot brain?

Authors:  Nino Stocchetti
Journal:  Intensive Care Med       Date:  2003-09       Impact factor: 17.440

Review 2.  Critical care issues in the early management of severe trauma.

Authors:  Alberto Garcia
Journal:  Surg Clin North Am       Date:  2006-12       Impact factor: 2.741

Review 3.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Effect of Hyperosmolar Therapy on Outcome Following Spontaneous Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study.

Authors:  Manan Shah; Lee Birnbaum; Jennifer Rasmussen; Padmini Sekar; Charles J Moomaw; Jennifer Osborne; Anastasia Vashkevich; Daniel Woo
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-01-03       Impact factor: 2.136

5.  Therapeutic Hypothermia Reduces Intracranial Pressure and Partial Brain Oxygen Tension in Patients with Severe Traumatic Brain Injury: Preliminary Data from the Eurotherm3235 Trial.

Authors:  Liam M C Flynn; Jonathan Rhodes; Peter J D Andrews
Journal:  Ther Hypothermia Temp Manag       Date:  2015-05-19       Impact factor: 1.286

Review 6.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

7.  Challenges for Molecular Neuroimaging with MRI.

Authors:  Victor S Lelyveld; Tatjana Atanasijevic; Alan Jasanoff
Journal:  Int J Imaging Syst Technol       Date:  2010-03       Impact factor: 2.000

Review 8.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

9.  Fixed negative charge and the Donnan effect: a description of the driving forces associated with brain tissue swelling and oedema.

Authors:  Benjamin S Elkin; Mohammed A Shaik; Barclay Morrison
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-02-13       Impact factor: 4.226

10.  Single bolus 30% hypertonic saline for refractory intracranial hypertension.

Authors:  E H Major; P O'Connor; B Mullan
Journal:  Ir J Med Sci       Date:  2014-02-15       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.